MRNA-LNP Encapsulation Protocol

• 

  Effective method for vaccine development using RNA

  Once the RNA is wrapped inside an LNP, it can sneak right into our cells. Right as the RNA gets inside of our cell it tells the cell to create a special protein from this virus or bacteria that could harm us. At that point, our immune system is educated about this protein and creates an enemy of body to body it. Thus, when we come across the actual virus/bacteria at a later stage, our immune system is already primed to attack them before they can make us ill. 

  
  

• 

  Customizable encapsulation process for mRNA delivery

  The mRNA-LNP Encapsulation Protocol is particularly flexible and can be adapted for a variety of experimental needs. This can prove to be extremely helpful functionality. For instance, scientists can select which lipids to formulate the LNP with, so that they are more or less robust — as desired. They can also control the size of the LNP, which influences how easy it is for cells to get the dose. This flexibility allows these methods to be well-suited for a wide variety of experiments or treatments. 

  
  

• 

  Improved drug delivery system with mRNA-LNP encapsulation

  This approach is not just for making vaccines; it can even be used to make new treatments for a large number of other diseases. That means, for instance, they could use this approach to deliver mRNA into cancer cells in order to instruct them not to proliferate or just kill them. It is quite significant in cancer treatment. This method could also be useful in delivering mRNA to injured cells — like after a heart attack —to promote healing and regrowth. It indicates that the mRNA-LNP Encapsulation Protocol has a variety of applications which can significantly improve our health. 

  
  

Why choose Yaohai MRNA-LNP Encapsulation Protocol?

• Robust Supply Chain & Manufacturing Capabilities

  Yaohai Bio-Pharma, a top 10 producer of mRNA-LNP Encapsulation Protocol, specializes in microbial fermentation. We have set up a modern facility with advanced facilities as well as robust RD manufacturing capabilities. Five production lines for drug substances complying with GMP standards for microbial purification and ferment along with two automated fill and finish lines for vials as well as cartridges as well as pre-filled needles are readily available. The available fermentation scales range between 100L and 2000L. Vial filling specifications cover 1ml - 25ml. the pre-filled cartridge or syringe filling specifications are between 1-3ml. The production workshop is cGMP certified and offers the availability of commercial and clinical samples. Our plant produces big molecules that are exported to all over the world.

• Customization, Efficiency & Cost-Effectiveness

  mRNA-LNP Encapsulation Protocol has experience in manufacturing biologics that are that are derived from microorganisms. We provide tailored RD as well as manufacturing solutions, while minimising the risk. We have experimented with a variety of techniques, such as recombinant cellular subunits of vaccines (including peptides), growth factors, hormones and the cytokines. We have specialized in multiple microorganisms like yeast extracellular and intracellular secretion (yields up to 15g/L) and bacteria intracellular soluble and inclusion bodies (yields up to 10g/L). We also have the BSL-2 fermentation platform to develop bacterial vaccines. We are experts in improving processes, increasing product yields, and decreasing production costs. With an effective technology team, we ensure timely and quality project delivery and bring your products to market faster.

• Professional Expertise & Extensive Experience

  mRNA-LNP Encapsulation Protocol is a leading in microbial biologics CDMO. Our focus has been on microbial-produced vaccines and therapeutics that are suited for human, veterinary, as well as pet health management. We have the most cutting-edge RD platforms and manufacturing technology which cover the entire procedure beginning with the development of microbial strains and cell banking, to process and method development, to commercial and clinical production which ensures successful delivery of innovative solutions. Over time, we have accumulated vast knowledge of microbial-based bio processing. Over 200 projects have been successfully completed, and we assist our clients to comply with regulations like those of US FDA and EU EMA. We also help them to navigate Australia TGA and China NMPA. Our professional expertise and extensive experience allows us to quickly respond to market demands and provide bespoke CDMO services.

• Quality System & Global Regulatory Compliance

  Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates quality control and regulatory matters. We have a quality system which is in line with current GMP standards and international regulations. Our regulatory team is knowledgeable in global regulatory frameworks to accelerate biological launches. We ensure traceable manufacturing processes and top-quality products that are compliant with the requirements of the US FDA, EU EMA, Australia TGA, and mRNA-LNP Encapsulation Protocol. Yaohai BioPharma has successfully passed the audit on site of the European Union's qualified Person (QP) for our GMP quality system and production site. In addition, we've cleared the first certification audits of the ISO9001 Quality Management System, ISO14001 Environmental Management System, and ISO45001 Occupational Health and Safety Management System.

Related product categories

• MRNA Plasmid Manufacturing
• MRNA-LNP Encapsulation Protocol

Not finding what you're looking for?
Contact our consultants for more available products.